Subacute sclerosing panencephalitis: A clinical appraisal
- PMID: 24339595
- PMCID: PMC3841616
- DOI: 10.4103/0972-2327.120497
Subacute sclerosing panencephalitis: A clinical appraisal
Abstract
Introduction: Subacute sclerosing panencephalitis (SSPE) is a rare chronic, progressive encephalitis affecting primarily children and young adults, caused by a persistent infection of immune resistant measles virus. The aim of the present study is to describe the clinical profile and natural history of patients with SSPE.
Methods: We collected data of patients with SSPE during 2004-2010 who fulfilled Dyken's criteria. We analyzed demographical, clinical, electrophysiological, and imaging features.
Results: Study included 34 patients, 26 (76.5%) males with age of onset from 3 to 31 years. Twenty one patients were below 15 years of age formed childhood SSPE and 13 above 15 years of age constituted adult onset group. 85.3% had low-socioeconomic status. Eleven received measles vaccination and seven were unvaccinated. 59.9% patients had measles history. Most common presenting symptom was scholastic backwardness (52.5%) followed by seizures (23.5%). Three patients each had cortical blindness, macular degeneration, decreased visual acuity, and optic atrophy. Electroencephalographic (EEG) showed long interval periodic complexes and cerebrospinal fluid anti-measles antibody was positive in all. Magnetic resonance imaging was done in 70.5% with was abnormal in 52.5%. Mean incubation period of SSPE after measles was 9.6 years. The follow-up duration was 1-10 years, (average of 2 years). Only one patient died from available data of follow-up, 9 were stable and 10 deteriorated in the form of progression of staging.
Conclusion: SSPE is common in low-socioeconomic status. The profile of adult onset did not differ from childhood onset SSPE, except for a longer interval between measles infection and presence of the ophthalmic symptom as presenting feature in adult onset group.
Keywords: Measles; myoclonus; subacute sclerosing panencephalitis.
Conflict of interest statement
Similar articles
-
Subacute Sclerosing Panencephalitis (SSPE): Experience from a Tertiary-Care Pediatric Center.J Neurosci Rural Pract. 2022 Feb 10;13(2):315-320. doi: 10.1055/s-0041-1740612. eCollection 2022 Apr. J Neurosci Rural Pract. 2022. PMID: 35694059 Free PMC article.
-
Subacute sclerosing panencephalitis: Disease profile in early childhood.Arch Pediatr. 2025 Apr;32(3):175-183. doi: 10.1016/j.arcped.2024.11.010. Epub 2025 Mar 19. Arch Pediatr. 2025. PMID: 40107908
-
The Enigma of Autoimmunity: A Case of Subacute Sclerosing Panencephalitis in a Patient Diagnosed With Systemic Lupus Erythematosus.Cureus. 2023 Apr 15;15(4):e37602. doi: 10.7759/cureus.37602. eCollection 2023 Apr. Cureus. 2023. PMID: 37197115 Free PMC article.
-
Adult-onset subacute sclerosing panencephalitis: case reports and review of the literature.Mov Disord. 1997 May;12(3):342-53. doi: 10.1002/mds.870120313. Mov Disord. 1997. PMID: 9159729 Review.
-
Subacute sclerosing panencephalitis.J Neurol. 2008 Dec;255(12):1861-71. doi: 10.1007/s00415-008-0032-6. Epub 2008 Oct 14. J Neurol. 2008. PMID: 18846316 Review.
Cited by
-
Optical Coherence Tomography Angiographic Follow-Up in a Case of Subacute Sclerosing Panencephalitis and Unilateral Necrotising Retinitis.Neuroophthalmology. 2023 Nov 22;48(2):142-151. doi: 10.1080/01658107.2023.2284914. eCollection 2024. Neuroophthalmology. 2023. PMID: 38487359 Free PMC article.
-
Subacute Sclerosing Panencephalitis (SSPE): Experience from a Tertiary-Care Pediatric Center.J Neurosci Rural Pract. 2022 Feb 10;13(2):315-320. doi: 10.1055/s-0041-1740612. eCollection 2022 Apr. J Neurosci Rural Pract. 2022. PMID: 35694059 Free PMC article.
-
Neuroleptic malignant syndrome as a presenting feature of subacute sclerosing panencephalitis.J Neurovirol. 2018 Feb;24(1):128-131. doi: 10.1007/s13365-017-0602-4. Epub 2017 Dec 14. J Neurovirol. 2018. PMID: 29243130
-
Subacute Sclerosing Panencephalitis: A Clinical, Radiological, and Outcome Study of 144 Cases.Ann Indian Acad Neurol. 2025 May 1;28(3):346-352. doi: 10.4103/aian.aian_1048_24. Epub 2025 May 27. Ann Indian Acad Neurol. 2025. PMID: 40432323 Free PMC article.
-
Clinical and magnetic resonance study of a case of subacute sclerosing panencephalitis treated with ketogenic diet.BMJ Neurol Open. 2021 Jul 23;3(2):e000176. doi: 10.1136/bmjno-2021-000176. eCollection 2021. BMJ Neurol Open. 2021. PMID: 34396129 Free PMC article.
References
-
- Agnarsdottir G. Subacute sclerosing panencephalitis. In: Waterson AP, editor. Recent Advances in Clinical Virology. New York: Churchill Livingstone; 1977. pp. 21–49.
-
- Dyken PR. Subacute sclerosing panencephalitis. Current status. Neurol Clin. 1985;3:179–96. - PubMed
-
- Centers for Disease Control (CDC). Subacute sclerosing panencephalitis surveillance -United States. MMWR Morb Mortal Wkly Rep. 1982;31:585–8. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources